BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36854891)

  • 1. In silico analysis of the association between long non-coding RNA family with sequence similarity 99 member A (FAM99A) and hepatic cancer.
    Sun M; Lv S; Zhong J
    IET Syst Biol; 2023 Apr; 17(2):83-94. PubMed ID: 36854891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
    Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
    BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA FAM99A modulated YAP1 to affect trophoblast cell behaviors in preeclampsia by sponging miR-134-5p.
    Xu B; Geng X; Liu X; Liu Y
    Braz J Med Biol Res; 2020; 53(12):e9732. PubMed ID: 33111745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA FAM99A is downregulated in preeclampsia and exerts a regulatory effect on trophoblast cell invasion, migration and apoptosis.
    He T; Qiao Y; Lv Y; Wang J; Hu R; Cao Y
    Mol Med Rep; 2019 Aug; 20(2):1451-1458. PubMed ID: 31173227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comprehensive roles of lncRNA FAM99A/FAM99B in hepatocellular carcinoma: Expressions, regulatory mechanisms and functional pathway analysis.
    Jin H; Li Y; Qin S; Li Q; Mao Y; Zhao L
    Life Sci; 2024 May; 349():122710. PubMed ID: 38740325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serum long noncoding RNA FAM99A in patients with hypertensive disorder complicating and its clinical significance.
    Ge Q; Zhao J; Qu F
    Blood Press Monit; 2022 Aug; 27(4):233-238. PubMed ID: 35258024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma.
    Fan L; Tang Y; Li J; Huang W
    Sci Rep; 2023 Jan; 13(1):335. PubMed ID: 36611046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
    Ji D; Chen GF; Liu X; Zhu J; Sun JY; Zhang XY; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12964-12970. PubMed ID: 30556902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis
    Zheng X; Gou Y; Jiang Z; Yang A; Yang Z; Qin S
    Front Oncol; 2021; 11():740557. PubMed ID: 34765550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinoma.
    Wang X; Zhou X; Liu J; Liu Z; Zhang L; Gong Y; Huang J; Yu L; Wang Q; Yang C; Liao X; Yu T; Han C; Zhu G; Ye X; Peng T
    Int J Oncol; 2019 Oct; 55(4):860-878. PubMed ID: 31432149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
    Du W; Chen W; Shu Z; Xiang D; Bi K; Lu Y; Zhang X; Li L; Diao H
    Epigenomics; 2020 Aug; 12(15):1303-1315. PubMed ID: 32772564
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
    Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of long non-coding LOC285194 predicts tumour progression and poor prognosis of hepatocellular carcinoma after curative hepatectomy.
    Qiu J; Pan G; Li M
    Postgrad Med J; 2020 Feb; 96(1132):79-83. PubMed ID: 31494574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
    Zhuang H; Cao G; Kou C; Li D
    J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
    Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
    Front Immunol; 2022; 13():859730. PubMed ID: 35669771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
    Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
    Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.
    Wu L; Liao W; Wang X; Zhao Y; Pang J; Chen Y; Yang H; He Y
    Bioengineered; 2021 Dec; 12(2):10302-10318. PubMed ID: 34709970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.